Matters pertaining to strengthening regulatory procedures at the Food and Drug Administration
2026 · 3rd Quarter (July 1 - Sep 30)
MASSACHUSETTS BIOTECHNOLOGY COUNCIL
Filed by NOVEL STRATEGIES (FKA) PRISM GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 21, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- NOVEL STRATEGIES (FKA) PRISM GROUP
- Filing UUID
- 4ce88e11-e52e-4050-bf13-a2e4ffebecfa
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.